Humacyte adds Scott Coward and Paul Kuznik to board of directorsSep 28Peopleacellular tissue engineered vesselHumacyte, Inc.
Humacyte registers two Symvess trials: adolescent Phase 3 study and adult Phase 4 real-world studyAug 13Weekly roundup, 2 itemsacellular tissue engineered vesselHumacyte, Inc.
Humacyte reports ATEV outperformed AV fistula in Phase 3 dialysis trialAug 12Quarterly updateacellular tissue engineered vesselHumacyte, Inc.
Humacyte posts trauma trial results, registers new Phase 2a coronary CTEV study for CABGJul 29Weekly roundup, 2 itemsacellular tissue engineered vesselHumacyte, Inc.
Sign inSign in